anmelden
OMX Copenhagen 20
1.539,57
PKT
+38,10
PKT
+2,54
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 21.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.06.18 | Novo Nordisk buy | UBS AG | |
| 12.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 08.06.18 | Novo Nordisk buy | UBS AG | |
| 31.05.18 | Novo Nordisk Reduce | HSBC | |
| 30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
| 30.05.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 08.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 03.05.18 | Novo Nordisk Verkaufen | DZ BANK | |
| 03.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.05.18 | Novo Nordisk buy | UBS AG | |
| 03.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.05.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.05.18 | Novo Nordisk buy | UBS AG | |
| 02.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.04.18 | Novo Nordisk buy | UBS AG | |
| 25.04.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 20.04.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 18.04.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.04.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 12.04.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 11.04.18 | Novo Nordisk market-perform | Bernstein Research | |
| 27.03.18 | Novo Nordisk buy | UBS AG | |
| 19.03.18 | Novo Nordisk market-perform | Bernstein Research | |
| 08.03.18 | Novo Nordisk Underweight | Barclays Capital | |
| 05.03.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 26.02.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 22.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.02.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.02.18 | Novo Nordisk Hold | Kepler Cheuvreux |